MUCINOUS ADENOCARCINOMA
Clinical trials for MUCINOUS ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new MUCINOUS ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for MUCINOUS ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major trial aims to tame dozens of rare, neglected cancers with immune power combo
Disease control OngoingThis large national trial is testing whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) can help control over 50 different types of rare cancers that have few or no standard treatment options. It enrolled over 800 adults whose rare cancers had progressed …
Matched conditions: MUCINOUS ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Major trial tests new combo to fight back when ovarian cancer returns
Disease control OngoingThis large, late-stage trial is for people whose ovarian, fallopian tube, or primary peritoneal cancer has returned after initial successful treatment. It aims to find the best way to control the cancer by testing whether adding a drug called bevacizumab to standard chemotherapy,…
Matched conditions: MUCINOUS ADENOCARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Scientists try to turn 'Cold' tumors 'Hot' to fight spreading colon cancer
Disease control OngoingThis study is testing if a standard chemotherapy drug (oxaliplatin) can make advanced colon cancer more visible to the immune system. Researchers then add an immunotherapy drug (nivolumab) to see if this combination can stop the cancer from growing for a longer time. The trial is…
Matched conditions: MUCINOUS ADENOCARCINOMA
Phase: PHASE2 • Sponsor: University Hospital, Akershus • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC